Fundraising FoxLumira Ventures — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste.
BiotechDigital HealthHealthtechMedical DevicesDelray Beach, US
Rick Geoffrion(Founder, President and CEO & Board Member)inRichard Geoffrion(Executive Officer, Director)Robert Henkin(Director)
BoardTakahide Koda(Director)
Board seatGerry Brunk· per SEC Form D
Co-investorsRemiges Ventures, Inc.DeepWork CapitalFlorida Opportunity Fund
Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products.
BiotechHealthtechToronto, CA
Ken d'Entremont(Executive Officer, Director)inRoland Boivin(Executive Officer)inTerri Shoemaker(Executive Officer)in
BoardStephen Nelson(Director)Adele Gulfo(Director)
Board seatPeter van der Velden· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.